A special type of acoustic pulse, properly tuned and administered, can activate the body’s natural tissue repair mechanism. The same mechanism is used by the body to replace cells that continually die of “old age” and to repair damage from wounds and disease. The acoustic pulses are generated by a proprietary electromechanical device and applied extracorporeally.

The technology works in any viable tissue. Experiments with laboratory animals have demonstrated anatomical and functional improvement in models of renal disease, diabetes, Parkinson’s disease, traumatic muscle injury, peripheral nerve injury, stress urinary incontinence, fecal incontinence and pelvic organ prolapse, among others. The technology has the potential to revolutionize the treatment of many diseases and disorders without drugs, implants or surgery.

Tom F. Lue, MD, ScD (Hon), FACS – Co-founder;Principal Scientific Advisor.

Dr. Lue is Professor and Emil Tanagho Endowed Chair in Clinical Urology at the University of California San Francisco and medical director of the Knuppe Molecular Urology Laboratory. Dr. Lue is an internationally recognized expert on treatment of male sexual dysfunction and a pioneer in surgical methods to treat refractory ED. His research team proved that PDE5 inhibitors enhance erection in animals, providing the scientific basis for Viagra, Levitra and Cialis. He is also an expert on incontinence and developed the first animal model of female stress urinary incontinence,now used widely to study potential treatments. He is co-inventor of the sacral stimulation method of treating urge incontinence, the technology underlying Medtronic’s Interstim product line. Dr. Lue graduated with highest honors from the Kaohsiung Medical University in Taiwan and completed his urologic training at the State University of New York Downstate Medical Center. He has authored or co-authored twelve books and more than 380 publications. He is the recipient of numerous honors, including the Gold Cystoscope Award from the American Urological Association and an award for most innovative research from the American Foundation of Urologic Disease